Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CRISPR
48 Articles Available
0
2
Can't find what you're looking for? Try our
advanced search
.
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
PAO-09-23-CL-09
Lipid Nanoparticle Development
Lipid Technology for Delivery of Gene-Editing Therapies
PAO-11-022-CL-18
CRISPR Research Innovation
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
PR-M08-22-05
CRISPR Clinical Trial
SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
PR-M04-22-11
Regulatory
FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
PR-M03-22-03
Gene Therapy
Beyond 2020: Looking into the Crystal Ball for Gene Therapy
PAO-01-21-CL-03
CRISPR RNPs
CRISPR RNPs and the Future of Cell and Gene Therapy
PAP-Q3-20-CL-002
Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand
PR-M08-20-NI-43
Gene Editing
Vertex Announces New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies
PR-M06-20-NI-017
CRISPR-Cas9
How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?
PAP-Q1-20-NI-003
CRISPR-Cas9
CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway
PAP-Q4-19-CL-011
Cell and Gene Therapy
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
PR-M11-19-NI-023
CRISPR
Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain
PAO-M09-19-NI-008
Virus
New Insights into Virus Evasion Tactics
PAO-M00-19-NI-003
CRISPR
Scientists Edit Stem Cell–Derived Neurons Using CRISPR
PAO-M08-19-NI-039
CRISPR-Cas
Editing Many Sites at Once With CRISPR-Cas
PAO-M08-19-NI-032
CRISPR
Biomaterials Smarten Up With CRISPR
PR-M08-19-NI-068
CRISPR
Editing Adult Blood Stem Cells Could Treat Blood Disorders
PAO-M08-19-NI-029
CRISPR
Using CRISPR to Treat Muscular Dystrophy
PAO-M08-19-NI-021
CRISPR
CRISPR Gene Editing of Babies Could Take Place in Russia
PAO-M06-19-NI-021
Cell and Gene Therapy
Gene Editing Solutions with Off-the-Shelf GMP CRISPR/Cas9 Nucleases
PAO-06-2019-CL-002
CRISPR
CRISPR Tech is Going Gold
PAO-M05-19-NI-040
CRISPR
CRISPR Used to Correct Genes in Mouse Fetuses that Cause Lung Disease
PAO-M05-19-NI-005
CRISPR
Researchers Use Gene Editing with CRISPR to Treat Lethal Lung Diseases before Birth
PR-M04-19-NI-069
«
0
2
»
.svg)
